Privia Health Group (PRVA) Insider Trading & Ownership $20.07 -0.06 (-0.30%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Privia Health Group (NASDAQ:PRVA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.20%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$4.75 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$3.91 M Get PRVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Privia Health Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PRVA Insider Buying and Selling by Quarter Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Privia Health Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/10/2024Parth MehrotraCEOSell135,142$18.50$2,500,127.00 6/11/2024Adam BoehlerDirectorBuy364$16.50$6,006.00 5/29/2024Adam BoehlerDirectorBuy5,306$16.50$87,549.00 5/23/2024Thomas A MccarthyDirectorBuy10,000$16.37$163,700.00 5/21/2024Adam BoehlerDirectorBuy277,565$16.17$4,488,226.05 5/10/2024David MountcastleCFOSell2,232$17.88$39,908.16 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/10/2024Parth MehrotraCEOSell13,869$17.88$247,977.72 5/10/2024Thomas BartrumEVPSell1,506$17.88$26,927.28 4/30/2024David MountcastleCFOSell2,320$18.42$42,734.40 4/30/2024Matthew Shawn MorrisDirectorSell11,059$18.42$203,706.78 4/30/2024Parth MehrotraCEOSell12,219$18.42$225,073.98 4/30/2024Thomas BartrumEVPSell2,252$18.42$41,481.84 4/2/2024David MountcastleCFOSell3,933$17.77$69,889.41 1/24/2024William M SullivanDirectorSell9,951$23.03$229,171.53 12/28/2023William M SullivanDirectorSell12,000$23.97$287,640.00 (Data available from 1/1/2013 forward) PRVA Insider Trading Activity - Frequently Asked Questions Who is on Privia Health Group's Insider Roster? The list of insiders at Privia Health Group includes Adam Boehler, Advisors L.L.C. Mbd, David Mountcastle, Jeffrey B Butler, Matthew Shawn Morris, Parth Mehrotra, Thomas A Mccarthy, Thomas Bartrum, and William M Sullivan. Learn more on insiders at PRVA. What percentage of Privia Health Group stock is owned by insiders? 14.20% of Privia Health Group stock is owned by insiders. Learn more on PRVA's insider holdings. Which Privia Health Group insiders have been buying company stock? The following insiders have purchased PRVA shares in the last 24 months: Adam Boehler ($4,581,781.05), and Thomas A Mccarthy ($163,700.00). How much insider buying is happening at Privia Health Group? Insiders have purchased a total of 293,235 PRVA shares in the last 24 months for a total of $4,745,481.05 bought. Which Privia Health Group insiders have been selling company stock? The following insiders have sold PRVA shares in the last 24 months: Advisors L.L.C. Mbd ($536,348,811.53), David Mountcastle ($352,045.29), Matthew Shawn Morris ($8,035,963.82), Parth Mehrotra ($15,286,901.60), Thomas Bartrum ($3,702,570.70), and William M Sullivan ($8,884,145.29). How much insider selling is happening at Privia Health Group? Insiders have sold a total of 26,201,965 Privia Health Group shares in the last 24 months for a total of $572,610,438.23 sold. Privia Health Group Key ExecutivesMr. Parth Mehrotra (Age 45)CEO & Director Compensation: $1.19M1 recent tradesMr. David Mountcastle CPA (Age 54)MBA, Executive VP, CFO & Principal Accounting Officer Compensation: $713.72kMr. Thomas Bartrum (Age 56)Executive Officer Compensation: $533.02kMr. Sarath DegalaChief Operating OfficerMr. Chris VoigtExecutive VP & Chief Technology OfficerMr. Robert P. BorchertSenior Vice President of Investor Relations & Corporate CommunicationsMs. Dana Fields CPAChief Audit & Compliance OfficerMr. Edward Christopher Fargis Esq.Executive VP, General Counsel, Chief Legal Officer & Corporate SecretaryMs. Jenny HardingChief People OfficerMr. Jay StevensSenior VP & Chief Growth Officer More Insider Trading Tools from MarketBeat Related Companies Hims & Hers Health Insider Ownership Guardant Health Insider Ownership Option Care Health Insider Ownership Sotera Health Insider Ownership Veracyte Insider Ownership BrightSpring Health Services Insider Ownership LifeStance Health Group Insider Ownership Surgery Partners Insider Ownership Addus HomeCare Insider Ownership PACS Group Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:PRVA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
